While it may not be an instantly familiar condition, its effects are easily recognizable in…
karnottNovember 6, 2026
Meet the incoming CBR Graduate Award Program (GAP) Cohort for 2026-27! Over the next year,…
karnottNovember 5, 2026
Cryptococcal meningoencephalitis is among the most prevalent invasive fungal diseases, posing a threat to immunocompromised…
karnottNovember 5, 2026
Zymeworks Signs Global License and Collaboration Agreement With Pharma Giant Roche Worth up to $813M
Zymeworks, a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse…
karnottNovember 4, 2026
More than 190 doctoral students and 64 postdoctoral fellows were recognized for their achievements in…
karnottNovember 4, 2026
A UBC chemist who uses catalytic and photochemical reactions to construct complex molecules—often in order…
karnottNovember 3, 2026
Six graduate students and postdoctoral fellows from the UBC Faculty of Pharmaceutical Sciences have received…
karnottNovember 3, 2026
Drs. Yusuke Shiraishi (left) and Jan Vanwelkenhuyzen (right) There was no tricks, just treats for…
karnottNovember 2, 2026
The Indigenous Pathways Acceleration Hub will create culturally-grounded pathways for students interested in medicine and…
karnottNovember 2, 2026
